CD4 and hepatocellular carcinoma: Therefore, researchers believe that increase in Tregs may exert adverse effects on the HCC disease prognosis (Wilke et al., 2010), and an augmented ratio of effector CD4+/Treg cells represent a better prognosis for HCC (Kalathil et al., 2019).